These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry. Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858 [TBL] [Abstract][Full Text] [Related]
3. Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps. Lucas E; Niu S; Aguilar M; Molberg K; Carrick K; Rivera-Colon G; Gwin K; Wang Y; Zheng W; Castrillon DH; Chen H Am J Surg Pathol; 2023 Sep; 47(9):1019-1026. PubMed ID: 37314146 [TBL] [Abstract][Full Text] [Related]
4. Management of endometrial precancers. Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL; Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535 [TBL] [Abstract][Full Text] [Related]
5. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Monte NM; Webster KA; Neuberg D; Dressler GR; Mutter GL Cancer Res; 2010 Aug; 70(15):6225-32. PubMed ID: 20631067 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions. Niu S; Molberg K; Castrillon DH; Lucas E; Chen H Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539494 [TBL] [Abstract][Full Text] [Related]
7. β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions. Aguilar M; Chen H; Sahoo SS; Zheng W; Grubman J; SoRelle JA; Lucas E; Castrillon DH Am J Surg Pathol; 2023 May; 47(5):618-629. PubMed ID: 36939046 [TBL] [Abstract][Full Text] [Related]
8. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis. Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743 [TBL] [Abstract][Full Text] [Related]
9. Specific Biomarker Expression Patterns in the Diagnosis of Residual and Recurrent Endometrial Precancers After Progestin Treatment: A Longitudinal Study. Chen H; Lucas E; Strickland AL; Carrick K; Gwin K; Castrillon DH; Rivera-Colon G; Niu S; Molberg KH; Zheng W Am J Surg Pathol; 2020 Oct; 44(10):1429-1439. PubMed ID: 32931681 [TBL] [Abstract][Full Text] [Related]
10. Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome. Wyvekens N; Mutter GL; Nucci MR; Kolin DL; Parra-Herran C Histopathology; 2024 Oct; 85(4):579-589. PubMed ID: 38785042 [TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy. Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731 [TBL] [Abstract][Full Text] [Related]
12. Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer. Liu N; Lin W; Wang Y; Yao Z; Rivera-Colon G; Li Y; Carrick KS; Chen H; Lucas E; Zheng W Int J Gynecol Pathol; 2024 Sep; 43(5):494-505. PubMed ID: 38293998 [TBL] [Abstract][Full Text] [Related]
13. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN]. Zhou WX; Liang ZY; Gao J; Liu TH Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346 [TBL] [Abstract][Full Text] [Related]
14. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Baak JP; Lees JA; Weng LP; Eng C J Natl Cancer Inst; 2000 Jun; 92(11):924-30. PubMed ID: 10841828 [TBL] [Abstract][Full Text] [Related]
15. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066 [TBL] [Abstract][Full Text] [Related]
16. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia. Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618 [TBL] [Abstract][Full Text] [Related]
17. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia. Trabzonlu L; Muezzinoglu B; Corakci A Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778 [TBL] [Abstract][Full Text] [Related]
18. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions]. Xiong Y; Xiong YY; Zhou YF Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187 [TBL] [Abstract][Full Text] [Related]
19. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma. Xiong Y; Xiong YY; Zhou YF Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231 [TBL] [Abstract][Full Text] [Related]
20. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia. Yi X; Zheng W Curr Opin Obstet Gynecol; 2008 Feb; 20(1):20-5. PubMed ID: 18197001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]